Diclofenac Potassium Powder, For Solution
Product Images NDC 51672-4240

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Potassium (NDC 51672-4240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Taro Pharmaceuticals U.s.a., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diclofenac 01)

FDA Label Image

Figure 1 (Diclofenac 02)

Figure 1 (Diclofenac 02)
This text seems to be a table showing percentage of subjects in a study related to Diclofenac potassium oral solution compared to a placebo over a period of time in hours. The data indicates the percentage of subjects at different time intervals ranging from 0 hours to 225 hours.*
FDA Label Image

Principal Display Panel (50 mg Packet Carton)

Principal Display Panel (50 mg Packet Carton)
This text provides information about Diclofenac Potassium packets containing 50 mg of the active ingredient. It includes details on the inactive ingredients, dosage instructions, and directions for use. The product is meant to be mixed with water and consumed immediately. Safety warnings regarding phenylalanine content are also included. Pharmacies should dispense a Medication Guide to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.